Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Fulgent Genetics Inc
(NQ:
FLGT
)
23.49
+0.12 (+0.51%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 21, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Fulgent Genetics Inc
< Previous
1
2
3
4
Next >
Fulgent Reports Second Quarter 2024 Financial Results
August 02, 2024
From
Fulgent Genetics, Inc.
Via
Business Wire
Fulgent to Announce Second Quarter 2024 Financial Results on Friday, August 2, 2024
July 11, 2024
From
Fulgent Genetics, Inc.
Via
Business Wire
Fulgent Data at ASCO 2024 Highlights Antitumor Activity from Lead Therapeutic Oncology Candidate, FID-007, in Head and Neck Cancer
June 03, 2024
From
Fulgent Pharma
Via
Business Wire
Fulgent Announces Upcoming Presentation of Clinical Data for Its Lead Therapeutic Oncology Candidate, FID-007, at ASCO 2024 Annual Meeting
May 24, 2024
From
Fulgent Pharma
Via
Business Wire
Moffitt Cancer Center and Fulgent Pharma Join Forces to Revolutionize Cancer Therapeutics
May 14, 2024
From
Fulgent Pharma
Via
Business Wire
Fulgent Reports First Quarter 2024 Financial Results
May 03, 2024
From
Fulgent Genetics, Inc.
Via
Business Wire
Fulgent Genetics to Announce First Quarter 2024 Financial Results on Friday, May 3, 2024
April 11, 2024
From
Fulgent Genetics, Inc.
Via
Business Wire
Fulgent Reports Fourth Quarter and Full Year 2023 Financial Results
February 28, 2024
From
Fulgent Genetics, Inc.
Via
Business Wire
Fulgent Genetics to Announce Fourth Quarter and Full Year 2023 Financial Results on Wednesday, February 28, 2024
February 13, 2024
From
Fulgent Genetics, Inc.
Via
Business Wire
Fulgent to Participate in the Piper Sandler 35th Annual Healthcare Conference
November 14, 2023
From
Fulgent Genetics, Inc.
Via
Business Wire
Fulgent Shares Data from Two Poster Presentations at SITC 2023 Annual Meeting
November 03, 2023
From
Fulgent Genetics, Inc.
Via
Business Wire
Fulgent Reports Third Quarter 2023 Financial Results
November 03, 2023
From
Fulgent Genetics, Inc.
Via
Business Wire
Fulgent Announces Two Poster Presentations at SITC 2023 Annual Meeting
October 25, 2023
From
Fulgent Genetics, Inc.
Via
Business Wire
Fulgent Genetics to Announce Third Quarter 2023 Financial Results on Friday November 3, 2023
October 17, 2023
From
Fulgent Genetics, Inc.
Via
Business Wire
Fulgent Reports Second Quarter 2023 Financial Results
August 04, 2023
From
Fulgent Genetics, Inc.
Via
Business Wire
Exagen Inc. Appoints Paul Kim to Board of Directors
July 24, 2023
From
Exagen Inc.
Via
GlobeNewswire
Fulgent Genetics to Announce Second Quarter 2023 Financial Results on Friday, August 4, 2023
July 18, 2023
From
Fulgent Genetics, Inc.
Via
Business Wire
Fulgent Data at ASCO 2023 Highlights Progress for Its Lead Therapeutic Oncology Candidate, FID-007, in Various Cancers
June 05, 2023
From
Fulgent Genetics, Inc.
Via
Business Wire
Fulgent Announces Upcoming Presentation of Clinical Data for Its Lead Therapeutic Oncology Candidate, FID-007, at ASCO 2023 Annual Meeting
May 18, 2023
From
Fulgent Genetics, Inc.
Via
Business Wire
Fulgent Reports First Quarter 2023 Financial Results
May 05, 2023
From
Fulgent Genetics, Inc.
Via
Business Wire
Fulgent Genetics to Announce First Quarter 2023 Financial Results on Friday May 5, 2023
April 20, 2023
From
Fulgent Genetics, Inc.
Via
Business Wire
Fulgent Reports Fourth Quarter and Full Year 2022 Financial Results
February 28, 2023
From
Fulgent Genetics, Inc.
Via
Business Wire
Fulgent Genetics Launches New Beacon787 Expanded Carrier Screening Panel
February 28, 2023
From
Fulgent Genetics, Inc.
Via
Business Wire
Fulgent to Participate in the Raymond James & Associates’ 44th Annual Institutional Investors Conference
February 23, 2023
From
Fulgent, Inc.
Via
Business Wire
Fulgent Genetics to Announce Fourth Quarter and Full Year 2022 Financial Results on Tuesday, February 28, 2023
February 14, 2023
From
Fulgent Genetics, Inc.
Via
Business Wire
NASDAQ:FLGT Long Term Investor Alert: Investigation of Potential Wrongdoing at Fulgent Genetics, Inc.
February 09, 2023
San Diego, CA -- (SBWIRE) -- 02/09/2023 -- An investigation was announced for current long-term investors in shares of Fulgent Genetics, Inc. (NASDAQ:FLGT) concerning potential breaches of fiduciary...
Via
SBWire
FULGENT ALERT: Bragar Eagel & Squire, P.C. is Investigating Fulgent Genetics, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
January 13, 2023
From
Bragar Eagel & Squire
Via
GlobeNewswire
INVESTIGATION ALERT REMINDER: Scott+Scott Attorneys at Law LLP Investigates Fulgent Genetics, Inc.’s Directors and Officers for Breach of Fiduciary Duties – FLGT
January 10, 2023
From
Scott+Scott Attorneys at Law LLP
Via
Business Wire
Fulgent Expands Board of Directors with Addition of Reggie Groves
January 03, 2023
From
Fulgent Genetics, Inc.
Via
Business Wire
INVESTIGATION ALERT: Scott+Scott Attorneys at Law LLP Investigates Fulgent Genetics, Inc.’s Directors and Officers for Breach of Fiduciary Duties – FLGT
November 28, 2022
From
Scott+Scott Attorneys at Law LLP
Via
Business Wire
< Previous
1
2
3
4
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.